Recorded Chinese product: 烟酸占替诺注射液烟酸占替诺注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H20043243
生产企业Manufacturer
- 黑龙江迪龙制药有限公司Chinese legal name: 黑龙江迪龙制药有限公司
主要成分Active Ingredients
- 烟酸占替诺Yansuan Zhanti Nuo
药物知识说明
国药准字H20043243是一种在国家药监局注册认定的药品。该药品含有烟酸占替诺-ad61e157等成分。
该药品关联的活性成分包括：烟酸占替诺Yansuan Zhanti Nuo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：黑龙江迪龙制药有限公司Chinese legal name: 黑龙江迪龙制药有限公司。
您可以探索含有相同成分的其他药品：烟酸占替诺-ad61e157成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 烟酸占替诺注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 烟酸占替诺Yansuan Zhanti Nuo.
Manufacturers recorded for this product: 黑龙江迪龙制药有限公司Chinese legal name: 黑龙江迪龙制药有限公司.
Explore other medicines containing the same ingredient: 烟酸占替诺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 烟酸占替诺注射液Recorded Chinese product: 烟酸占替诺注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:0.3g2 mL:0.3 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 黑龙江迪龙制药有限公司Chinese legal name: 黑龙江迪龙制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20043243
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20043243
Manufacturer
Chinese legal name: 黑龙江迪龙制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20043243
生产企业
黑龙江迪龙制药有限公司(国产)
适应症
本品缺血性脑血管病。亦用于冠心病、高脂血症和高纤维蛋白原的辅助用药。
用法用量
静脉滴注。起始剂量一日0.3g(1支),逐渐增加至一日0.6～0.9g(2～3支),加入10%葡萄糖注射液500ml中静脉滴注。
不良反应
面部潮红、口干、胸闷、皮疹、四肢红斑及风团.极个别患者出现脑出血及脑疝
禁忌
发作期的心肌梗塞、出血性脑血管病的急性期、急性出血者及脱水、二尖瓣狭窄及明显心功能不全者禁用。
注意事项
1.临床应用时,应密切注意患者颅压变化情况。|2.消化性溃疡及血压不稳定者慎用。
贮藏
遮光，密闭（10～30℃）保存。
规格
2ml:0.3g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.